(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.38%) $966.30
(-0.36%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
3.13% $ 0.339
Live Chart Being Loaded With Signals
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders...
Stats | |
---|---|
Volumen de hoy | 251 101 |
Volumen promedio | 441 245 |
Capitalización de mercado | 5.64M |
EPS | $0 ( 2024-03-05 ) |
Próxima fecha de ganancias | ( $-1.480 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0400 |
ATR14 | $0.00300 (0.87%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-29 | Golembiewski Michael Joseph | Buy | 417 | Common Stock |
2024-01-12 | Mehra Raj | Buy | 70 383 | Stock Option (right to buy) |
2024-01-12 | Golembiewski Michael Joseph | Buy | 24 537 | Stock Option (right to buy) |
2024-01-04 | Pascoe Richard W | Buy | 1 666 | Stock Option (right to buy) |
2024-01-04 | Dalesandro Margaret | Buy | 1 666 | Stock Option (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 92 transactions |
Buy: 14 639 227 | Sell: 4 987 490 |
Volumen Correlación
Seelos Therapeutics Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
DCFC | 0.951 |
WKHS | 0.937 |
ADPT | 0.934 |
NDLS | 0.933 |
SLGG | 0.927 |
WOOF | 0.926 |
ORPH | 0.919 |
RGF | 0.919 |
TSLA | 0.916 |
PRTS | 0.916 |
10 Correlaciones Más Negativas | |
---|---|
BCOR | -0.939 |
MCAA | -0.931 |
LCYAU | -0.926 |
KVSC | -0.926 |
EBACU | -0.922 |
BCSA | -0.919 |
GHRS | -0.917 |
IVCB | -0.916 |
HORI | -0.914 |
LPCN | -0.913 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Seelos Therapeutics Inc Correlación - Moneda/Commodity
Seelos Therapeutics Inc Finanzas
Annual | 2023 |
Ingresos: | $2.20M |
Beneficio Bruto: | $2.15M (97.41 %) |
EPS: | $-7.73 |
FY | 2023 |
Ingresos: | $2.20M |
Beneficio Bruto: | $2.15M (97.41 %) |
EPS: | $-7.73 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-53 000.00 (0.00 %) |
EPS: | $-21.48 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.730 |
Financial Reports:
No articles found.
Seelos Therapeutics Inc
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico